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 Abstract 
Background: Sleep disordered breathing is a common and serious feature of many paediatric 
conditions, and is particularly a problem in children with Down Syndrome.  Overnight pulse 
oximetry is recommended as an initial screening test, but it is unclear how overnight 
oximetry results should be interpreted and how many nights should be recorded.  
Methods: This retrospective observational study evaluated night to night variation using 
statistical measures of inter-rater reliability for 214 children referred to a paediatric 
respiratory clinic, who required overnight oximetry measurements.  This included 30 
children with Down Syndrome. We measured length of adequate trace, basal SpO2, number 
of desaturations (>4% SpO2 drop for >10 seconds) per hour (“adjusted index”), and time 
with SpO2 <90%.  We classified oximetry traces into normal or abnormal based on 
physiology. 
Results: 132 out of 214 (62%) children had 3 technically adequate nights’ oximetry, including 
13 out of 30 (43%) children with Down Syndrome.  Intra-class correlation co-efficient for 
adjusted index was 0.54 (95% CI 0.20 to 0.81) among children with Down Syndrome, and 
0.88 (95% CI 0.84 to 0.91) for children with other diagnoses.  Negative predictor value of a 
negative first night predicting two subsequent negative nights was 0.2 in children with Down 
Syndrome, and 0.55 in children with other diagnoses. 
Conclusions: There is substantial night to night variation in overnight oximetry readings 
among children in all clinical groups undergoing overnight oximetry.  This is a more 
pronounced problem in children with Down Syndrome.  Increasing the number of attempted 
nights recording from one to three provides useful additional clinical information. 
 
 
  
Introduction 
 
Overnight pulse oximetry is commonly used as a screening tool for sleep disordered 
breathing in children. Formal polysomnography is the gold standard to diagnose sleep 
disordered breathing[1], but this is not often available as a first line investigation due to 
patient and parent burden, need for inpatient admission and cost.  For example, a survey in 
2005 identified only ten paediatric sleep laboratory beds in the whole of the UK [2]. 
Overnight pulse oximetry is advantageous as it is readily available, does not require 
admission to hospital overnight and has minimal upheaval for children and parents.   
Although it is recommended as a first line screening test only, for many children overnight 
pulse oximetry is the only diagnostic test available to identify sleep disordered breathing due 
to the difficulties of accessing polysomnography [2] [3] [4]. There is no clear research data 
on the levels of overnight oximetry abnormality which predict clinical benefit from 
intervention, although best practice guidelines have been published [1] [2] [5] [6].  
Additionally, some small studies have shown night to night variation in sleep studies [7] [8], 
but it is unclear how significant this variation is in clinical practice. This a clinically important 
area as UK guidelines from Working Party on Sleep Physiology and Respiratory Control 
Disorders in Childhood (SPARDIC) endorsed by the Royal College of Paediatrics and Child 
Health (RCPCH) recommend annual screening for Obstructive Sleep Apnoea (OSA) for all 
children with Downs Syndrome (DS) up to 6 years of age [2], due to the high risk of 
developing pulmonary hypertension in this group.  The Down Syndrome Medical Interest 
Group (also endorsed by RCPCH) recommend a symptom based screen with referral for 
further testing if positive [9] . If the SPARDIC guideline were to be fully implemented, a very 
large number of children would undergo overnight oximetry, with the attendant difficulties 
in interpreting results. It is not likely to be feasible in the near future for formal 
polysomnography to be available to all children with Down Syndrome annually, therefore it 
is vitally important to be able to best understand the strengths, limitations and repeatability 
of overnight oximetry.    
At the Royal Belfast Hospital for Sick Children our clinical practice has been to record 3 
consecutive nights of overnight oximetry readings when screening for sleep disordered 
breathing.  This practice was instituted by the senior author (MDS) who, when first setting 
up home oximetry in Northern Ireland many years ago had observed marked night to night 
variability especially in DS. The present study aims to assess whether recording 3 nights 
provides additional useful data, or whether recording only one night of oximetry would be 
adequate.  Specifically we assess, (1) does recording three nights data increase the chance of 
having a technically sufficient and interpretable nights recording? (2) how repeatable are 
results night to night? (3) how clinically significant are night to night variations in overnight 
oximetry recordings (i.e. does variation lead to a change in clinical classification)?   
Children with DS are known to often be restless sleepers [10], and we hypothesised that 
they would have more night to night variability compared to other clinical groups and would 
thus require oximetry over three nights. 
Methods 
This was a retrospective observational study, designed as a service development and quality 
improvement project.  Overnight oximetry recordings were taken only when clinically 
indicated as part of routine practice.  Children were classified according to diagnostic 
category by their clinician at the time of oximetry recording into one of the following 
categories; Downs Syndrome (DS), Neuromuscular disease (such as Duchenne’s Muscular 
Dystrophy) (NMD), Central Nervous System Disorders (such as cerebral palsy) (CNS), Cranio-
facial structural abnormalities (such as achondroplasia or Pierre Robin Syndrome) 
(structural), and other children referred with suspected OSA with no other diagnosis (OSA).  
Anonymised data only were collected by researchers.  No institutional ethical approval was 
required as there was no change to usual care, and only anonymised data were collected in 
this service development project. 
Overnight pulse oximetry was recorded by means of a Nonin 9600 Avant Digital Pulse 
Oximeter (Nonin Medical Inc, Plymouth MN, USA) and Nellcor neonatal-adult SpO2 sensor. 
Parents were instructed how to use the pulse oximeter and took the device home.  All pulse 
oximetry readings were recorded by parents at home in the child’s normal surroundings.  
The sensor was attached to either the child’s finger or big toe. After three nights, parents 
returned the oximeter and data were downloaded and analysed using nVision software 
(Nonin Medical Inc, Plymouth MN, USA).    
Length of time of adequate artefact free reading (hours), basal oxygen saturations (defined 
as average of all SpO2 readings not included in a desaturation event) (% SpO2), length of 
time with oxygen saturation <90% (expressed as a percentage of length of recording) and 
average number of desaturations per hour (defined as >4% drop in SpO2 for >10seconds, the 
“adjusted index”) were extracted from the Nonin nVision software and into the anonymised 
study database. SpO2 was averaged over 4 second increments. 
A technically adequate reading was defined as one with ≥4 hours of suitable oximetry 
recording. A normal pulse oximetry reading was defined as basal SpO2 ≥94%; <2% of total  
time with SpO2<90% ; and adjusted index <5. An oximetry recording with abnormalities in 
any of these perimeters was defined as abnormal.  These criteria for normal readings follow 
those recommended by the Royal College of Paediatrics and Child Health[2] and are in line 
with published normal values for children [11]. 
Data were analysed in Stata 11 (StataCorp. 2009. Stata Statistical Software: Release 11. 
College Station, TX: StataCorp LP) and StatsDirect version 3 (StatsDirect Ltd. StatsDirect 
statistical software. http://www.statsdirect.com. England: StatsDirect Ltd. 2013.).  Bland-
Altman plots were used to graphically display agreement of basal SpO2, adjusted index and 
time with SpO2 below 90% between nights.  95% limits of agreement [12] and two-way 
single measures intraclass correlation coefficients (ICC) were calculated.  For pair-wise 
comparisons of continuous variables across clinical groupings Kruskal-Wallis (non-
parametric) tests were used.  For comparisons of discrete variables, a chi squared test was 
used.  A Fleiss’ kappa value was calculated for agreement of results across all 3 nights.  
Following convention, we defined a kappa value of >0.6 as substantial agreement, and a 
Lin’s correlation coefficient of >0.8 as the minimum acceptable standard [13] .  
Results 
214 children had overnight home pulse oximetry recordings between December 2010 and 
July 2014 arranged through the Royal Belfast Hospital for Sick Children.  The average age of 
children was 4.2 years old (range 2 months to 18.3 years). The majority of the group were 
otherwise well children with signs and symptoms leading to suspicion of obstructive sleep 
apnoea (OSA group) (114 out of 214 (53%), median age 3.5 years), and this group was used 
as a baseline group for comparison. There were 23 (11%) children with neuromuscular 
disorders (NMD group) (median age 12.3 years), 30 with Down syndrome (DS group) 
(median age 4.8), 26 (12%) with central nervous system disorders (CNS group) (median age 
3.1 years) and 21 (10%) with structural cranio-facial abnormalities (structural group) (median 
age 4.4 years). Children with NMD were older than children in OSA group (12.3 vs. 3.5 years, 
p<0.01). 
The mean length of time of adequate recording was 8.4 hours (st. dev. 2.9 hours). Regarding 
the technical adequacy of recording usable results; 25 of our 214 (12%) children did not have 
sufficient data recorded on the first night to make any assessment of sleep ventilation.  Of 
these, 18 (8%) children went on to record adequate readings on subsequent nights. 132 / 
214 (62%) children had adequate recordings on all three nights.  Seven children (1 DS, 1 CNS, 
5 OSA) had no usable data recorded on any of the three nights.  No children (0/23) with 
neuromuscular disease had unusable oximetry recordings on night 1, whereas 6/30 (20%) 
children with DS had an inadequate reading on night 1.  This difference was not statistically 
significant (p = 0.16).  19/122 (16%) children under age 5 had unusable readings on night 1, 
compared with 7/91 (8%) of children 5 and older.  This difference was not statistically 
significant (p=0.08). 
There was marked night to night variation in the oximetry traces of many of the children 
over the three nights.  Table 1 summarises the within-patient difference, standard deviation 
of differences, and 95% limits of agreement for 3 nights pairwise comparisons.  Figure 1 
shows example Bland-Altman plots showing agreement between basal SpO2, adjusted index, 
and time with SpO2 <90% in night 1 and night 2 (see e-figure 1 for comparisons nights 1 and 
3, and 2 and 3). Table 2 shows the intraclass correlation coefficient (ICC) across all three 
nights, by clinical condition.  The ICC tended to be lower for children with DS, this difference 
was significant when considering the night to night variability of adjusted index. 
 N = Means (SD) Mean 
difference 
Standard 
deviation of 
differences 
Bland-Altman 95% 
limits of agreement 
Basal oxygen SpO2 (%) 
Night 1 – night 2 179 Night 1 =  96.1 (2.79) 
Night 2 = 96.2 (2.47) 
0.076 2.41 -4.6 to 4.8 
Night 1 – night 3 147 Night 1 = 96.4 (2.3) 
Night 3 = 96.7 (2.02) 
0.28 1.78 -3.2 to  3.7 
Night 2 – night 3 150 Night 2 = 96.4 (2.28) 
Night 3 = 96.6 (2.01) 
0.15 1.45 -2.7 to  3.0 
Adjusted Index 
Night 1 – night 2 178 * Night 1 = 5.44 (7.30) 
Night 2 = 6.21 (8.76) 
- 0.76 4.91 -8.8 to 10.4 
Night 1 – night 3 147 Night 1 = 5.21 (7.58) 
Night 3 = 5.04 (8.00) 
0.17 4.80 -9.6 to  9.3 
Night 2 – night 3 * 149 * Night 2 = 5.92 (8.79) 
Night 3 = 5.29 (8.00) 
0.63 4.45 -9.4 to  8.1 
Time with SpO2 < 90% (as % of time recorded) 
Night 1 – night 2 179 Night 1 =  4.92 (11.9) 
Night 2 = 4.75 (10.9) 
0.17 10.6 -20.8 to  20.6 
Night 1 – night 3 147 Night 1 = 4.11 (10.7) 
Night 3 = 3.04 (8.77) 
1.07 9.59 -19.8 to 17.7 
Night 2 – night 3 150 Night 2 = 3.66 (8.86) 
Night 3 = 3.12 (8.76) 
0.53 6.56 - 13.4 to 12.3 
Table 1 Mean value for each night (standard deviation), mean within-patient difference, 
standard deviation of with-patient differences and 95% limits of agreement across three 
pairs of nights, for each of the three values tested (* One patient had no data of 
desaturations per hour recorded on night 2). 
  
Intraclass Correlation Co-efficient (95% confidence interval) 
Clinical Diagnosis    
 Basal Spo2 Adjusted Index Time SpO2 < 90% 
 Central Nervous System 
Disorder (CNS), N=14 
0.74 (0.49 to 0.90) 0.84 (0.66 to 0.94) 0.49 (0.16 to 0.77) 
 Suspected Obstructive 
Sleep Apnoea (no other 
diagnosis), N=69 
0.72 (0.62 to 0.81) 0.90 (0.85 to 0.93) 0.63 (0.51 to 0.73) 
 Neuromuscular disorder, 
N=20 
0.67 (0.45 to 0.84) 0.57 (0.32 to 0.78) 0.60 (0.35 to 0.80) 
 Structural cranio-facial 
abnormalities, N=15 
0.91 (0.79 to 0.96) 0.94 (0.87 to 0.98) 0.83 (0.66 to 0.94) 
Pooled all non-DS diagnoses, N= 
118 
0.74 (0.67to 0.80) 0.88 (0.84 to 0.91) 0.65 (0.15 to 0.78) 
Down Syndrome, N=13 0.48 (0.15 to 0.77) 0.54 (0.20 to 0.81) 0.48 (0.15 to 0.78) 
Table 2 Intra-class correlation coefficient of measurements over three nights recording 
oximetry. 
As described above, overnight oximetry readings were categorised to be either normal, or 
abnormal based on the physiology observed. Overall 117 out of 207 (57%) were normal on 
the first adequate night.  73 out of 109 (67%) children with suspected OSA only and no other 
clinical diagnosis had normal oximetry.  This was similar to the proportion of children with 
NMD, in whom 14 out of 23 (61%) had normal oximetry (p=0.58). Children with other 
diagnoses were less likely to have a normal first night; 9 out of 25 (36%) of children with CNS 
disorders (p<0.01), 9 out of 21 (43%) children with structural abnormalities (p=0.04) and 12 
out of 30 (41%) of children with DS (p=0.1) had normal first-night oximtery tracings. 
There was only moderate concordance of results from oximetry reading on consecutive 
nights.   Restricting the analysis to 132 children with three technically adequate nights 
oximetry recording, 84 out of 132 (65%) of children had a normal first night’s reading.  
However, nearly half (39 out of 84 (46%)) of these children had at least one abnormal 
reading on subsequent nights.  Table 3 shows these restricted results broken down by 
clinical category.  If we define a “true negative” to be a child with 3 consecutive normal 
readings, the overall negative predictor value of a first night’s normal reading is 0.53.   
Clinical diagnosis      
First night oximetry NORMAL and three nights oximetry recorded (N =84) 
 2nd and 3rd 
night both 
normal. 
2nd night 
abnormal, 3rd 
night normal. 
 
2nd night 
normal, 3rd 
night 
abnormal. 
2nd and 3rd night 
both abnormal 
Sub-total 
Central Nervous System 
Disorder 
2 0 1 1 4 
Suspected Obstructive 
Sleep Apnoea (no other 
diagnosis) 
33 3 7 12 55 
Neuromuscular disorder 5 4 1 3 13 
Cranial – facial 
abnormalities 
3 2 1 0 6 
Down Syndrome 2 1 0 3 6 
Total (all diagnoses) 45 10 10 19 84 
First night oximetry ABNORMAL and three nights oximetry recorded (N=48) 
 2nd and 3rd 
night both 
normal. 
2nd night 
abnormal, 3rd 
night normal. 
 
2nd night 
normal, 3rd 
night 
abnormal.. 
2nd and 3rd night 
both abnormal 
Sub-total 
Central Nervous System 
Disorder 
1 0 0 9 10 
Suspected Obstructive 
Sleep Apnoea (no other 
diagnosis) 
1 1 0 13 15 
Neuromuscular disorder 1 0 0 6 7 
Cranial – facial 
abnormalities 
0 3 0 6 9 
Down Syndrome 1 1 0 5 7 
Total (all diagnoses) 4 5 0 39 48 
Table 3 Number of children with normal or abnormal overnight oximetry readings on nights 2 
and 3, following either normal or abnormal night 1 reading, by clinical group.  Analysis 
restricted to 132 children with at three nights of technically adequate results. 
 
Fleiss’ kappa for interrater agreement across three nights for children with CNS was 0.63 
(p<0.01), OSA 0.51 (p<0.01), NMD 0.40 (p<0.01), Structural 0.44 (p<0.01), DS 0.33 (p=0.02). 
Overall, Fleiss’ kappa was 0.51 (p<0.01). 
Discussion 
There is a large amount of night to night variability in all children undergoing overnight pulse 
oximetry, this is especially true of children with DS.  Clearly there is a limit to how much 
oximetry data can be usefully be recorded and analysed, we suggest that it may be 
pragmatic to record three consecutive nights data rather than a single night.  This will 
increase the likelihood both of having any usable data and of detecting clinically important 
abnormalities. 
Sleep disordered breathing is a common paediatric diagnosis, and it is an important feature 
of a range of paediatric and congenital disorders. Accurately diagnosing sleep disordered 
breathing is important so as to allow intervention and prevent development of serious 
complications such as pulmonary hypertension.  Polysomnography is considered to be the 
gold standard for diagnosis[2], but it has significant drawbacks.  In addition to cost and 
access considerations, polysomnography usually measures only one night thus potentially 
missing important night-to-night variations [8] , and takes place in an artificial environment 
that could artefactually change sleep architecture in children.  In addition access to 
polysomnography is generally poor; a recent survey of practice in USA showed that most 
children who proceeded to surgery for sleep apnoea had never had a polysomnographic 
diagnosis [3] and in the UK a survey of paediatrics showed a large unmet need for sleep 
services and polysomnography[2].   Overnight pulse oximetry is much more readily available, 
can be undertaken in a child’s normal surroundings (thus likely reducing first night effect) 
and is feasible to repeat on consecutive nights in order to capture night to night variation.  
Inherent difficulties with overnight oximetry are that is can be affected by motion artefact 
and that it measures the whole night regardless of whether the child is awake or asleep.  
How best to screen for sleep disordered breathing is an increasingly important question as 
best practice guidelines recommend screening all children with neuromuscular disease 
(prevalence 1:3000) annually [14], in addition to screening all children with signs and 
symptoms raising suspicion of the diagnosis of OSA.  There are varying guidelines regarding 
DS (prevalence 1:1000), with one guideline recommending testing all children annually up to 
age 6 [2] and another suggesting symptom based screening [9]. This highlights that is 
currently a wide variation in practice around use of home screening and polysomnography – 
both in adults and children - and few large studies to provide evidence and guidance. 
We found that increasing the overnight oximetry readings from one night to three increases 
the chance of getting a technically adequate trace that is suitable for interpretation.  With 
one night’s recording 25 (12%) children failed to record adequate data.  However, with three 
nights recording only 7 (3%) had no adequate results.  There was a trend towards children 
with Down syndrome being less likely to have an adequate trace on the first night of 
attempted recording, although this wasn’t statistically significant. 
 
We found substantial night to night variation in oximetry results.  For instance concerning 
the adjusted index, the Bland-Altman 95% limits of agreement for difference between night 
1 and night 3 in the same patient were -9.6 to +9.3.  Although a proportion of this variation 
is caused by night to night variation in severity among children who had abnormal traces on 
both nights, much of this variation causes change in clinical classification.  We found a high 
proportion of children (46%) with a normal first night oximetry, going on to have subsequent 
abnormal nights.  This indicates that recording only one night’s data may miss clinically 
significant oximetry abnormalities.  In the absence of access to a gold standard measure 
(polysomography) in this cohort, if a “true negative” is defined as a child with three night’s 
normal oximetry then negative predictor value for a normal first nights oximetry trace is only 
0.53, suggesting that relying on only one night’s oximetry reading may misclassify children as 
having no sleep disordered breathing when they do actually have a clinically significant 
problem.   This fits with previous data on repeatability of oximetry studies [15], suggesting 
that a positive result may be sufficient to make a diagnosis of OSA, but that a negative result 
cannot rule out the diagnosis and in this instance the recommendation has been to move to 
formal polysomnography [1]. As with all diagnostic tools with a potential for variable results, 
it is important that interpretation of oximetry findings are put into the clinical context. 
 
There is limited literature about the repeatability of oximetry measures in polysomnography 
in the paediatric setting [7] [8]. One study of thirty children, which excluded patients with DS 
or any other medical diagnosis, showed a intraclass correlation of 0.86 for apnoeic index, 
and 0.71 for low SpO2 across two nights polysomnography [7]. This is similar to our findings 
for adjusted index and basal SpO2 among the non-DS children in our study.  However in that 
study, in contrast to our study, the observed variation didn’t lead to reclassification of any of 
the thirty patients as normal / abnormal across the two nights measured.  A larger adult 
study of 243 patients showed important night to night variation, with 28 adults having an 
abnormal night two polysomnograph (defined as >5 apnoeic-hypoxic events per hour) 
following a normal 1st night reading [16].  This suggests that our observed night to night 
variation is in keeping with night to night variation seen on polysomnography, and therefore 
is likely to represent a real phenomenon of within-patient night to night fluctuations, rather 
than night to night error in oximetry reading.  
 
In view of this clinically important night to night variability in overnight oximetry, we suggest 
that it may be useful to record more than one night’s oximetry data.  This is especially true in 
children with DS, who had a trend towards more night to night variability.  Although not 
formally assessed in this study, the marginal cost and inconvenience to patients and parents 
of recording three nights rather than one is thought to be minimal, whilst the extra data 
recorded may improve clinical management and decision making, and reduce the risk of 
missing clinically important abnormalities.  While polysomnography remains the gold 
standard it is not readily available, and resource limitations mean that is unlikely in the near 
future to be feasible to substantially increase the number of children undergoing 
polysomnography in order to meet SPARDIC recommendations to screen all children with 
Down Syndrome (or even all symptomatic children) for sleep disordered breathing annually 
[2,6].   It would seem prudent to invest more in sleep diagnostics to improve service, and 
this would be our recommendation in medium term. However, we suggest that in the 
interim, pending better availability of alternative modalities, recording three nights rather 
than one will make overnight oximetry an increasingly useful screening tool.  Current 
guidance is that while a positive result of pulse oximetry can be used to make a diagnosis of 
OSA, a negative result cannot rule it out and one should proceed to polysomnography and 
where this is not available clinicians must use their judgement whilst being mindful of the 
limitations of overnight oximetry [1].  In the absence of ready access to polysomnography 
studies, repeating the overnight oximetry may give more confidence in negative result. 
Newer technology such as mobile phone based oximetry combined with pulse rate 
variability has been demonstrated to have good diagnostic accuracy, and easily lends itself 
to multiple nights testing [4]. This is an increasingly important area because of the large 
number of children who are being recommended for screening for sleep disordered 
breathing. 
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What is already known about this topic 
 
Overnight polysomnography is the gold standard to diagnose sleep disordered breathing in 
children, but is difficult to access routinely. 
 
Overnight pulse oximetry is recommended for screening of sleep disordered breathing, but 
there is little evidence about how best to interpret overnight oximetry results. 
 
Children with Down Syndrome should be tested for sleep disordered breathing annually up 
to age 6 years. 
 
What this paper adds 
 
There is substantial within patient night to night variation when recording sequential nights 
of overnight oximetry. 
 
Many children investigated for suspected sleep disordered breathing (39 out of 84 in this 
study) with one normal night of oximetry go on to have abnormal oximetry in sequential 
subsequent nights. 
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